1. Kwak YH, Lee YJ, Lee JY, Nam EJ, Kim S, Kim YT, et al. Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer. Obstet Gynecol Sci. 2022; 65:223–5.
Article
2. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008; 26:884–9.
Article
3. Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012; 30:3786–91.
Article
4. Johnson LR, Nair RP, Sambasivan S, Mony RP, Gangadharan J, Kumar A, et al. Adenoid cystic carcinoma of vulva-11 years’ single-institution experience. J Obstet Gynaecol India. 2017; 67:196–201.
5. Ha HI, Chang HK, Park SJ, Lim J, Won YJ, Lim MC. The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea central cancer registry. Obstet Gynecol Sci. 2021; 64:444–53.
Article
6. Zach D, Kannisto P, Stenström Bohlin K, Moberg L, Kjölhede P. Can we extend the indication for sentinel node biopsy in vulvar cancer? A nationwide feasibility study from Sweden. Int J Gynecol Cancer. 2020; 30:402–5.
Article
7. Koual M, Benoit L, Nguyen-Xuan HT, Bentivegna E, Azaïs H, Bats AS. Diagnostic value of indocyanine green fluorescence guided sentinel lymph node biopsy in vulvar cancer: a systematic review. Gynecol Oncol. 2021; 161:436–41.
Article